diabetes glp-1 agonist glp-1_analogs [TUSOM Targeting GLP-1, GIP & GCG

And you also need an exit plan

Conclusion In conclusion, the emerging observation that some complications of diabetes are associated with an hyperactivation of RAAS has provided the pathophysiological basis to study the effects of GLP1-RA and SGLT2-i on RAAS to better explain the cardio-reno-protective effect demonstrated by the clinical trials, beyond their role on glucose control

In the CNS, endogenous GLP-1 acts primarily through vagal afferent signaling, transmitting information from the gastrointestinal tract to the brainstem [123, 124]

Additionally, insurance coverage continues to lag behind clinical evidence, particularly for cardiovascular indications in non-diabetic patients

Park, B